Published in Medicine and Law Weekly, October 15th, 2004
"The elevation of these talented individuals reflects our commitment to maximizing the resources of our team and enhancing the competitive position of our company," said Ronald Nutt, PhD, president and CEO of CTI Molecular Imaging.
"Our strategy is to capitalize on our leadership in PET tomography...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine and Law Weekly